Use of mathematical modelling to assess the impact of vaccines on antibiotic resistance (Q47606815)

4 February 2018

title

Use of mathematical modelling to assess the impact of vaccines on antibiotic resistance (English)

1 reference

4 February 2018

main subject

antibiotic resistance

1 reference

inferred from title

mathematical modelling

1 reference

6

Mark Jit

1 reference

4 February 2018

4

Nicholas G Davies

1 reference

4 February 2018

author name string

Katherine E Atkins

1

1 reference

4 February 2018

Erin I Lafferty

2

1 reference

4 February 2018

Sarah R Deeny

3

1 reference

4 February 2018

Julie V Robotham

5

1 reference

4 February 2018

publication date

13 November 2017

1 reference

4 February 2018

Lancet Infectious Diseases

published in

1 reference

4 February 2018

Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

A theoretical examination of the relative importance of evolution management and drug development for managing resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Improving Control of Antibiotic-Resistant Gonorrhea by Integrating Research Agendas Across Disciplines: Key Questions Arising From Mathematical Modeling

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Modelling the transmission of healthcare associated infections: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Modelling the epidemiology of infectious diseases for decision analysis: a primer

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Interim results of an ecological experiment - Conjugate vaccination against the pneumococcus and serotype replacement

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Perspective: a five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Antimicrobial-resistant bacteria in the community setting

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Mutation frequencies and antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Antiviral resistance and the control of pandemic influenza

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Antibiotic Restriction Might Facilitate the Emergence of Multi-drug Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Food animals and antimicrobials: impacts on human health

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Genomic Characterization of Colistin Heteroresistance in Klebsiella pneumoniae during a Nosocomial Outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Achieving global targets for antimicrobial resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Targeting imperfect vaccines against drug-resistance determinants: a strategy for countering the rise of drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Interactions between Streptococcus pneumoniae and influenza virus: a mutually beneficial relationship?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Impact of the pneumococcal conjugate vaccine on otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Did introduction of pneumococcal vaccines in the Netherlands decrease the need for respiratory antibiotics in children? Analysis of 2002 to 2013 data.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

The effect of universal influenza immunization on antibiotic prescriptions: an ecological study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

What Happens When "Germs Don't Get Killed and They Attack Again and Again": Perceptions of Antimicrobial Resistance in the Context of Diarrheal Disease Treatment Among Laypersons and Health-Care Providers in Karachi, Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Short- and long-term effects of pneumococcal conjugate vaccination of children on penicillin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Penicillin-resistant pneumococcal meningitis: high antibiotic exposure impedes new vaccine protection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Antibiotic innovation may contribute to slowing the dissemination of multiresistant Streptococcus pneumoniae: the example of ketolides.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Controlling antimicrobial resistance through targeted, vaccine-induced replacement of strains

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Interaction of Vaccination and Reduction of Antibiotic Use Drives Unexpected Increase of Pneumococcal Meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Carriage burden, multiple colonization and antibiotic pressure promote emergence of resistant vaccine escape pneumococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Impact of capsular switch on invasive pneumococcal disease incidence in a vaccinated population

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

How could preventive therapy affect the prevalence of drug resistance? Causes and consequences

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Origin and proliferation of multiple-drug resistance in bacterial pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

No coexistence for free: neutral null models for multistrain pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930478-4

1 reference

7 January 2021

10.1016/S1473-3099(17)30478-4

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018